Hans Biomed (042520.KQ) Stock Price
Hans Biomed Price
Revenue has compounded at 14.1% per year over the past 19 years to 89.78 B KRW. Earnings per share have grown at 10.7% per year over the last 16 years. Hans Biomed's net margin stands at -34.9%, down from -30.9% several years earlier. Hans Biomed currently offers a dividend yield of about 0.63%. The payout ratio is around 16% of earnings. The dividend has grown at 9.1% per year over the past 10 years.
Hans Biomed stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Hans Biomed business model & stock analysis
Frequently asked questions about Hans Biomed
5 analysts currently rate the Hans Biomed stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Hans Biomed to generate revenue of 141.70 B KRW and earnings per share of 919.00 KRW.
Converted at the current exchange rate, the Hans Biomed share trades at 12.75 EUR (19,000.00 KRW).
The expected revenue of Hans Biomed is 141.70 B KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Hans Biomed is 11.94 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Hans Biomed is currently 20.67. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Hans Biomed stock.
The price-to-sales ratio (P/S) of Hans Biomed is currently 1.74. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Hans Biomed stock.
The Eulerpool Quality Score for Hans Biomed is 2/10.
The ISIN of Hans Biomed is KR7042520007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Hans Biomed is 042520.KQ. The ticker symbol is used to trade Hans Biomed shares on the stock exchange.
Hans Biomed stock
Hans Biomed Peer Group
Hans Biomed FIGI
All fundamentals and in-depth analysis of Hans Biomed
Our stock analysis for Hans Biomed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hans Biomed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.